{"id":5876,"date":"2025-03-13T04:35:38","date_gmt":"2025-03-13T08:35:38","guid":{"rendered":"https:\/\/www.packagingindustrynews.com\/?p=5876"},"modified":"2025-03-13T04:35:38","modified_gmt":"2025-03-13T08:35:38","slug":"warburg-pincus-and-kkr-consortium-in-talks-to-acquire-gerresheimer","status":"publish","type":"post","link":"https:\/\/www.packagingindustrynews.com\/?p=5876","title":{"rendered":"Warburg Pincus and KKR consortium in talks to acquire Gerresheimer"},"content":{"rendered":"


\n<\/p>\n

\n
\n
\n \n <\/picture>
The consortium is reportedly unlikely to offer a large premium over Gerresheimer\u2019s current price. Credit: T. Schneider via Shutterstock.<\/figcaption><\/figure>\n<\/p><\/div>\n

A group comprising private equity companies Warburg Pincus and KKR is reportedly in discussions to acquire Gerresheimer, a German company specialising in packaging for medicines and beauty products.<\/p>\n

<\/p>\n

The companies became the leading contenders after joining forces, with other possible bidders such as Bain Capital withdrawing from the process, Bloomberg News<\/em><\/a> reported, citing people familiar with the matter.<\/p>\n

However, sources said that the Warburg Pincus-KKR consortium is unlikely to offer a large premium over Gerresheimer\u2019s current price, with key hurdles still remaining for a deal.<\/p>\n

Although the talks are progressing, a final agreement may take weeks, and the deal could still collapse, sources added.<\/p>\n

Gerresheimer, based in D\u00fcsseldorf, has already drawn interest from several private equity companies, according to the news agency.<\/p>\n

Last month, Gerresheimer enlisted advisors to gauge the interest<\/a> of prospective buyers, with Warburg Pincus, EQT, and KKR indicating early interest.<\/p>\n

Gerresheimer was seen as an attractive acquisition target due to its operations in two key sectors.<\/p>\n

Its cosmetics division makes plastic bottles and glass jars for perfumes and skincare while its pharma unit produces specialised packaging such as syringes, vials, injectors, inhalers, and wearable infusion devices.<\/p>\n

Since last year, the German company is said to have been exploring strategic options for its moulded glass business.<\/p>\n

Last December, Gerresheimer announced an investment<\/a> of \u20ac100m ($108.80m) in its Skopje facility in North Macedonia.<\/p>\n

The investment would see the addition of a syringe production hall at the facility, which produces plastic systems for the pharmaceutical industry.<\/p>\n

<\/p>\n

<\/p>\n

<\/p>\n

\n